Last reviewed: July 7, 2026
Last updated: July 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, originally developed for type 2 diabetes management, has become one of the most effective medications for weight loss when dosed properly. The key to success is not starting at a high dose, but rather beginning low and titrating upward based on tolerance and response. PlexusDx compounds pharmaceutical-grade semaglutide in licensed 503A pharmacies and personalizes dosing protocols for patients across all 50 states.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Semaglutide Dosing Works for Weight Loss
Semaglutide for weight loss follows a stepped dosing schedule that takes place over 16 to 20 weeks. Unlike some medications where you start at your target dose, semaglutide requires a gentle ramp-up to minimize nausea and allow your body to adapt. The standard protocol begins at 0.25 milligrams once weekly, then increases by 0.25 milligrams each month until reaching a maintenance dose. Most patients achieve meaningful weight loss results between 1.0 and 2.4 milligrams weekly, though some benefit from lower or higher doses depending on their metabolic profile.
The reason for this gradual approach is that semaglutide works by slowing stomach emptying and signaling fullness to your brain through the GLP-1 receptor pathway. When the dose increases too quickly, patients often experience gastrointestinal side effects like nausea or vomiting that can lead to treatment discontinuation. Starting low allows your digestive system to acclimate while your appetite naturally decreases, making the weight loss process more sustainable and tolerable.
Starting Dose and Titration Schedule for Weight Loss
The standard starting dose of semaglutide for weight loss is 0.25 milligrams injected subcutaneously once per week. This initial dose has minimal impact on appetite but serves as a safety benchmark to assess how your body responds. After one week at this dose, most patients experience no significant side effects, which signals readiness to move forward. Over the following four to five months, the dose increases in 0.25-milligram increments weekly until reaching a therapeutic dose of 1.0 to 2.4 milligrams per week.
The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
What Dose Produces Weight Loss Results
Research from the STEP clinical trial program demonstrated that weekly semaglutide doses of 1.0 to 2.4 milligrams produce meaningful weight loss, with patients losing an average of 10 to 18 percent of body weight over 68 weeks of treatment. The dose-response relationship shows that higher doses within this range generally correlate with greater weight loss, but the benefit plateaus around 2.4 milligrams. Patients who reach and maintain a dose of 2.0 milligrams or higher typically see the most dramatic reductions in appetite and sustained weight reduction.
Not every patient needs the maximum dose to achieve their goals. Some individuals respond powerfully to 1.0 or 1.5 milligrams weekly, experiencing substantial appetite suppression and fat loss. Others require gradual titration to 2.4 milligrams to reach their target weight loss. PlexusDx compounds your semaglutide at whatever dose your provider determines is optimal for your metabolism and health history, and the monthly cost remains the same regardless of dose level.
Personalized Dosing and Genetic Insights with PlexusDx
Individual variation in semaglutide response is significant and partly driven by genetics. Some patients carry genetic variants in or GIPR gene (rs1800437) that affect how sensitively their body responds to GLP-1 medications. Others may have FTO or MC4R variants that influence baseline appetite regulation and metabolic rate. PlexusDx offers the Precision Peptide Genetic Test ($298) to identify these pathways and inform a truly personalized dosing strategy.
Your PlexusDx provider reviews genetic insights alongside your clinical response to fine-tune your semaglutide dose over time. If you carry genetic variants suggesting higher GLP-1 receptor sensitivity, your provider may recommend slower titration or a lower maintenance dose to minimize side effects while maximizing weight loss. Conversely, if your genetics suggest lower medication responsiveness, your provider may recommend more aggressive titration toward the 2.0 to 2.4 milligram range. This precision approach ensures you reach your weight loss goal as efficiently and comfortably as possible.
Managing Side Effects During Dose Escalation
Nausea, vomiting, constipation, and reduced appetite are common during the first few weeks of semaglutide treatment and often intensify briefly after each dose increase. These side effects typically resolve within three to seven days as your body adapts. Taking semaglutide on the same day each week, eating smaller meals, staying hydrated, and consuming ginger or peppermint tea can reduce nausea. If side effects are severe or persistent, inform your PlexusDx provider—dose escalation can be delayed by one to two weeks to allow more time for adjustment.
Constipation is one of the more persistent side effects during semaglutide treatment and warrants proactive management. Increasing dietary fiber, drinking at least 80 ounces of water daily, and using a stool softener like docusate sodium can help. Some patients benefit from taking their semaglutide injection in the evening rather than the morning, which allows sleep to pass through the period of maximum appetite suppression. Serious side effects like pancreatitis or thyroid concerns are rare but require immediate medical attention and treatment discontinuation.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of semaglutide for weight loss?
Semaglutide weight loss treatment starts at 0.25 milligrams injected once weekly. This low starting dose allows your body to acclimate before weekly increases of 0.25 milligrams over the following 16 to 20 weeks. Most patients reach a therapeutic dose of 1.0 to 2.4 milligrams per week, where sustained weight loss becomes noticeable.
How much weight can you lose on semaglutide and at what dose?
Clinical trials show patients lose an average of 10 to 18 percent of body weight over 68 weeks when using weekly doses of 1.0 to 2.4 milligrams. Greater weight loss typically occurs at doses of 2.0 milligrams or higher, though individual results vary based on diet, exercise, genetics, and metabolic factors. PlexusDx personalizes your dose based on your response and genetic profile to optimize your results.
Does the price of PlexusDx semaglutide change if my dose increases?
No. PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and remains that price whether your dose stays at 0.25 milligrams or increases to 2.4 milligrams. Your dose may need to go up, but your price won't. HSA and FSA accounts are eligible, and no insurance or membership is required.
What are the side effects of increasing semaglutide doses?
Nausea, reduced appetite, vomiting, and constipation are common during dose increases but typically resolve within three to seven days. Eating smaller meals, staying hydrated, and increasing fiber intake help manage these effects. Serious side effects are rare, but severe or persistent symptoms should be reported to your PlexusDx provider immediately.
How does the PlexusDx Precision Peptide Genetic Test influence my dosing?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where to Give Ozempic Shot for Best Results: A Clear Guide
Navigating Nausea on Wegovy: What You Can Take and How to Find Relief